Alec Machiels - 31 Dec 2021 Form 5 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Issuer symbol
APLS
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
10 Feb 2022, 15:49:45 UTC
Previous filing
17 Dec 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -160,000 -38% $0.000000 259,544 22 Jul 2021 Direct F1
holding APLS Common Stock 250,000 31 Dec 2021 See footnote F2
holding APLS Common Stock 11,950 31 Dec 2021 See footnote F3
holding APLS Common Stock 150,000 31 Dec 2021 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 22, 2021, the reporting person transferred 160,000 shares of Apellis Pharmaceuticals, Inc. common stock to his spouse.
F2 The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
F3 Owned by the spouse of the reporting person.
F4 On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.